Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Pharmacology & Therapeutics
|
December 22, 1999
Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy
R Wolk, S M Cobbe, M N Hicks, et al.
European Journal of Pharmacology
|
March 19, 1999
Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model
R Wolk, K A Kane, S M Cobbe, et al.
Clinical Pharmacology and Therapeutics
|
July 10, 2009
Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects
R Wolk, D Chen, R W Clark, et al.
International Journal of Cardiology
|
November 15, 2000
Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris
B Bednarz, R Wolk, T Chamiec, et al.
International Journal of Cardiology
|
June 1, 1996
The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone
R Wolk, P Kulakowski, S Karczmarewicz, et al.
JAMA
|
December 22, 1975
Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG
S P Richman, G M Mavligit, R Wolk, et al.
The Journal of Extra-Corporeal Technology
|
May 7, 1996
Comparison of three methods to estimate heparin loading dose for cardiopulmonary bypass
T D Clark, J M Ecklund, M M McCall, et al.
Cardiovascular Research
|
October 18, 2000
Regional electrophysiological effects of left ventricular hypertrophy in isolated rabbit hearts under normal and ischaemic conditions
R Wolk, K P Sneddon, J Dempster, et al.
Clinical and Experimental Dermatology
|
May 12, 2018
Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis
L Fitz, W Zhang, C Soderstrom, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 21, 2017
Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight
M M Hutmacher, K Papp, S Krishnaswami, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Pharmacology & Therapeutics
|
December 22, 1999
Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy
R Wolk, S M Cobbe, M N Hicks, et al.
European Journal of Pharmacology
|
March 19, 1999
Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model
R Wolk, K A Kane, S M Cobbe, et al.
Clinical Pharmacology and Therapeutics
|
July 10, 2009
Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects
R Wolk, D Chen, R W Clark, et al.
International Journal of Cardiology
|
November 15, 2000
Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris
B Bednarz, R Wolk, T Chamiec, et al.
International Journal of Cardiology
|
June 1, 1996
The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone
R Wolk, P Kulakowski, S Karczmarewicz, et al.
JAMA
|
December 22, 1975
Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG
S P Richman, G M Mavligit, R Wolk, et al.
The Journal of Extra-Corporeal Technology
|
May 7, 1996
Comparison of three methods to estimate heparin loading dose for cardiopulmonary bypass
T D Clark, J M Ecklund, M M McCall, et al.
Cardiovascular Research
|
October 18, 2000
Regional electrophysiological effects of left ventricular hypertrophy in isolated rabbit hearts under normal and ischaemic conditions
R Wolk, K P Sneddon, J Dempster, et al.
Clinical and Experimental Dermatology
|
May 12, 2018
Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis
L Fitz, W Zhang, C Soderstrom, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 21, 2017
Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight
M M Hutmacher, K Papp, S Krishnaswami, et al.
Page
of 4